Harald Sommer Selected Research

Harald Sommer Research Topics

Disease

19	Breast Neoplasms (Breast Cancer) 10/2012 - 09/2003
16	Neoplasms (Cancer) 11/2017 - 12/2002
8	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 07/2007
6	Carcinoma (Carcinomatosis) 08/2012 - 01/2003
3	Leukopenia 01/2017 - 01/2010
3	Vomiting 10/2012 - 05/2006
3	Neoplasm Metastasis (Metastasis) 10/2012 - 06/2005
3	Nausea 10/2012 - 05/2006
2	Ascites 01/2017 - 07/2007
2	Thrombocytopenia (Thrombopenia) 01/2017 - 08/2008
2	Alopecia (Baldness) 10/2012 - 08/2008
2	Neutropenia 10/2012 - 08/2008
2	Endometrial Neoplasms (Endometrial Cancer) 05/2009 - 11/2007
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Febrile Neutropenia 10/2012
1	Thrombocytopenia 1 10/2012
1	Diarrhea 10/2012
1	Fatigue 10/2012
1	Infections 10/2012
1	Disease Progression 10/2012
1	Hand-Foot Syndrome 10/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2012
1	Obesity 01/2010
1	Weight Loss (Weight Reduction) 04/2009
1	Malnutrition (Nutritional Deficiencies) 04/2009
1	Residual Neoplasm 01/2009
1	Lymphopenia (Lymphocytopenia) 05/2006
1	Headache (Headaches) 05/2006
1	Fever (Fevers) 05/2006
1	Inflammation (Inflammations) 11/2004
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2002
1	Vaccinia 12/2002

Drug/Important Bio-Agent (IBA)

3	Hormones (Hormone)IBA 10/2012 - 11/2003
3	PlatinumIBA 01/2011 - 07/2008
3	Topotecan (Hycamtin)FDA LinkGeneric 01/2011 - 07/2008
3	Docetaxel (Taxotere)FDA Link 05/2010 - 01/2010
3	Monoclonal AntibodiesIBA 05/2009 - 03/2005
3	Thomsen-Friedenreich antigenIBA 01/2008 - 06/2005
3	Keratins (Keratin)IBA 01/2008 - 01/2003
3	Biological ProductsIBA 01/2007 - 11/2003
2	treosulfanIBA 01/2017 - 08/2012
2	Pharmaceutical PreparationsIBA 01/2017 - 05/2006
2	Vinorelbine (Navelbine)FDA LinkGeneric 10/2012 - 03/2010
2	Capecitabine (Xeloda)FDA Link 10/2012 - 03/2010
2	AnthracyclinesIBA 10/2012 - 03/2010
2	taxaneIBA 10/2012 - 01/2008
2	Carboplatin (JM8)FDA LinkGeneric 09/2012 - 08/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2012 - 08/2008
2	Indicators and Reagents (Reagents)IBA 05/2011 - 11/2003
2	Zoledronic Acid (Zometa)FDA Link 05/2010 - 05/2010
2	Gemcitabine FDA Link 05/2010 - 07/2008
2	CarbohydratesIBA 01/2008 - 01/2007
2	EpitopesIBA 01/2008 - 01/2007
2	Cytostatic AgentsIBA 01/2008 - 03/2006
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2007 - 06/2005
2	AntigensIBA 06/2005 - 12/2002
1	Phosphotransferases (Kinase)IBA 11/2017
1	Adenosine Triphosphate (ATP)IBA 11/2017
1	Adenosine Monophosphate (AMP)IBA 11/2017
1	Alkylating AgentsIBA 08/2012
1	Tumor Biomarkers (Tumor Markers)IBA 05/2010
1	Taxoids (Taxanes)IBA 03/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2010
1	Biomarkers (Surrogate Marker)IBA 01/2010
1	Activins (Activin)IBA 05/2009
1	inhibin-alpha subunitIBA 05/2009
1	Inhibins (Inhibin)IBA 05/2009
1	inhibin beta A subunitIBA 05/2009
1	Etoposide (VP 16)FDA LinkGeneric 07/2008
1	AntibodiesIBA 01/2008
1	Estrogen Receptor alphaIBA 11/2007
1	Estrogen Receptor betaIBA 11/2007
1	progesterone receptor AIBA 11/2007
1	Steroid Receptors (Steroid Receptor)IBA 11/2007
1	Epithelial Cell Adhesion MoleculeIBA 07/2007
1	catumaxomabIBA 07/2007
1	EnzymesIBA 05/2006
1	ertumaxomabIBA 05/2006
1	Biological FactorsIBA 01/2005
1	RadiopharmaceuticalsIBA 11/2004
1	Estrogen ReceptorsIBA 09/2003
1	Proteins (Proteins, Gene)FDA Link 12/2002
1	Viral ProteinsIBA 12/2002
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2002
1	VaccinesIBA 12/2002

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2017 - 01/2008
8	Therapeutics 10/2012 - 06/2005
3	Adjuvant Chemotherapy 05/2010 - 01/2008
2	Lymph Node Excision (Lymph Node Dissection) 11/2003 - 09/2003
1	Oral Administration 10/2012
1	Negative-Pressure Wound Therapy 05/2010
1	Combination Drug Therapy (Combination Chemotherapy) 01/2010
1	Treatment Delay 08/2008
1	Immunotherapy 07/2007
1	Gamma Cameras (Gamma Camera) 11/2004
1	Hysterectomy 12/2002